Objective: To assess the in vitro efficacy of doripenem against Pseudomonas aeruginosa
and Acinetobacter baumannii using Epsilometer strips. Study Design: Cross-sectional study …

At 24 h, sub-MIC doripenem and levofloxacin showed synergy against 21 of 25
Pseudomonas aeruginosa strains, sub-MIC doripenem and amikacin against 22 isolates …

Objective: To compare the in vitro efficacy of doripenem and imipenem against multi-drug
resistant (MDR) Pseudomonas aeruginosa from various clinical specimens. Study Design …

The aims of the study were to determine the in vitro activity of doripenem, a new
carbapenem, against a large number of bacterial pathogens and to propose zone diameter …

Background Despite the high mortality of patients with sepsis and carbapenem-resistant
bacteria infection, appropriate antimicrobial therapies are yet to be established. Here, we …

The in vitro activity of doripenem was evaluated against a recent collection of extended-
spectrum β-lactamase (ESBL)-producing Enterobacteriaceae and Pseudomonas …

Doripenem is a carbapenem bactericidal agent that demonstrates in vitro activity against a
wide variety of Gram-negative and Gram-positive pathogens. In vitro data show that …

Carbapenems have been the therapeutic choice for empirical treatment of serious infections
when multidrug-resistant Gram-negative organisms are suspected. Doripenem is a …

In vitro activity of doripenem and comparator antimicrobial agents was evaluated against
Gram-negative bacilli recently isolated from Brazilian private hospitals that were enrolled in …

Recently, doripenem has been approved for the treatment of nosocomial pneumonia (NP),
including ventilator-associated pneumonia (VAP). The E-test was performed to determine …